Recombinant Interferon-α2b Treatment for Chronic Hepatitis C. a Prospective Multicentre Study in Hungary

Interferon-α2b is widely used in the treatment of chronic hepatitis C. The aim of this multicentre study was to analyse the effect of prolonged recombinant interferon-α on liver functions and hepatitis C virus markers in serum. A further aim was to provide data on dosage and long-term administration of α-interferon. Eight liver units in universities and hospitals were involved in the open prospective study. Ninety-one patients were selected for the trial.